First-line PD-1 +/- CTLA-4 blockade in patients with deficient mismatch repair and/or microsatellite instability-high metastatic colorectal cancer.

Oncologist · 2025 · PMC12445664 · PMID 40833920

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Briefly, patients across all subgroups, except those with lung metastases, showed a trend towards superior PFS and OS with the anti-CTLA-4-based combination.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.